Ischemic stroke and dose adjustment of oral Factor Xa inhibitors in patients with atrial fibrillation

BACKGROUND: Oral Factor Xa inhibitors for the prevention of stroke in atrial fibrillation require dose adjustment based on certain clinical criteria, but the off-label use of the reduced doses is common. METHODS: Data from an observational registry including patients admitted with acute cerebral isc...

Descripción completa

Detalles Bibliográficos
Autores principales: Stoll, Svenja, Macha, Kosmas, Marsch, Armin, Gerner, Stefan T., Siedler, Gabriela, Fröhlich, Kilian, Volbers, Bastian, Strasser, Erwin F., Schwab, Stefan, Kallmünzer, Bernd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7320957/
https://www.ncbi.nlm.nih.gov/pubmed/32206901
http://dx.doi.org/10.1007/s00415-020-09795-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7320957/
https://www.ncbi.nlm.nih.gov/pubmed/32206901
http://dx.doi.org/10.1007/s00415-020-09795-3

Ejemplares similares